FINWIRES · TerminalLIVE
FINWIRES

Mineral Resources Prices $1.3 Billion in Senior Unsecured Notes to Refinance Existing Debt

-- Mineral Resources (ASX:MIN) said it has priced $650 million in 6% senior unsecured notes due May 2032 and $650 million in 6.25% senior unsecured notes due May 2034, in an offering to qualified institutional buyers, according to a Tuesday Australian bourse filing.

The company said the settlement is expected to occur in New York on April 29, with interest payable on May 1 and Nov. 1 each year, and the notes are guaranteed by its certain units.

The company will use the proceeds, together with cash on hand, to refinance its existing $625 million 8% senior unsecured notes due November 2027, fully repay the outstanding balance of its iron ore prepayment, and redeem $350 million of its existing $1.1 billion 9.25% senior unsecured notes due October 2028.

The transaction is expected to deliver finance cost savings of AU$48 million per year, decreasing the company's weighted average cost of debt to 7.4% from 8.4% and extending its weighted average tenor to five years from 3.1 years, the filing added.

Related Articles

Asia

Beijing Enlight Media Q1 Profit Falls 99%; Shares Down 8%

Beijing Enlight Media Co (SHE:300251) posted first-quarter attributable net profit of 23.3 million yuan, down 99% from 2.02 billion yuan the previous year.Earnings per share went down to 0.01 yuan from 0.69 yuan, according to a Wednesday filing with the Shenzhen bourse.Operating revenue fell 94% year over year to 190.6 million yuan from 2.97 billion yuan.Shares of the media company were down 8% in recent trade.

$SHE:300251
Asia

Enlight Media 2025 Profit Jumps 473%; Shares Fall 7%

Beijing Enlight Media (SHE:300251) posted 2025 attributable net profit of 1.67 billion yuan, up 473% from 292.0 million yuan the previous year.Earnings per share went up to 0.57 yuan from 0.10 yuan, according to a Wednesday filing with the Shenzhen bourse.Operating revenue jumped 155% year over year to 4.04 billion yuan from 1.59 billion yuan.Shares of the media company were down 7% in recent trade.

$SHE:300251
Asia

CR Double-Crane Pharma Gets Nod to Name Unit as Marketer of Endometriosis Drug

China Resources Double-Crane Pharmaceutical (SHA:600062) received approval from the National Medical Products Administration to change the marketing authorization holder of dienogest tablets, according to a Shanghai bourse filing on Wednesday.Under the approved supplementary application, the pharmaceutical company's subsidiary, CR Zizhu Pharmaceutical, becomes the marketing authorization holder, as well as the manufacturer of the endometriosis drug.

$SHA:600062